cyclosporine has been researched along with Pruritus in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (12.07) | 18.2507 |
2000's | 21 (36.21) | 29.6817 |
2010's | 25 (43.10) | 24.3611 |
2020's | 5 (8.62) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Feldman, SR; Ghamrawi, RI; Howell, AN; Strowd, LC | 1 |
Arents, BWM; Bohdanowicz, M; Burton, T; Di Giorgio, S; Drucker, AM; Ellis, AG; Flohr, C; Küster, D; Mashayekhi, S; Rochwerg, B; Schmitt, J; Siegels, D; Spuls, PI; Yiu, ZZN | 1 |
Jaworek, A; Jaworek, M; Matusiak, Ł; Szafraniec, K; Szepietowski, JC; Wojas-Pelc, A | 1 |
Chung, BY; Jung, MJ; Kang, SY; Kim, HO; Kim, JC; Kwak, IS; Park, CW; Um, JY | 1 |
Bergqvist, C; Chosidow, O; Fiani, C; Hua, C; Lebre, C; Ortonne, N; Simantov, A; Wolkenstein, P | 1 |
Al Habeeb, A; Chan, AW; Chang, J; Kassar, R; Lilly, LB; Rotstein, C | 1 |
Elmariah, SB | 1 |
Diaz, S; Gilbert, S; Koch, SN; Rendahl, A; Torres, SMF | 1 |
Hon, KL; Leung, AKC; Loo, SK; Ng, WGG | 1 |
Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
Cohen, DE; Miller, K; Stein, JA; Wu, TP | 1 |
Favrot, C | 1 |
Bensignor, E; Carmichael, J; Dip, R; Letellier, I; Roberts, E; Rosenkrantz, W; Strehlau, G | 1 |
Grattan, C; Marrouche, N | 1 |
Ferreira, MB; Kaplan, AP; Viegas, LP | 1 |
Cosgrove, SB; Davis, KR; King, VL; Little, PR; Stegemann, MR | 1 |
Bäumer, W; Olivry, T | 1 |
Adamek, Ł; Pomorski, Z; Szczepanik, M; Wilkołek, P; Zając, M | 1 |
Cena, T; Noli, C | 1 |
Camarero-Mulas, C; Daudén, E; de Argila, D; Gordillo, C; Montes-Torres, A | 1 |
Kamata, Y; Kina, K; Ko, KC; Matsuda, H; Ogawa, H; Ogawa, M; Takahashi, N; Takamori, K; Tominaga, M; Umehara, Y | 1 |
Friberg, C; Griffin, C; King, S; Roberts, ES; Roycroft, L; Speranza, C; Steffan, J | 1 |
Katagiri, K | 1 |
Deza, G; Giménez-Arnau, AM | 1 |
Kamata, Y; Takamori, K; Tominaga, M | 1 |
Kamino, H; Lane, TK; Meehan, S; Pomeranz, MK; Walters, RF | 1 |
Katsuta, O; Nakamura, M; Oda, T; Shii, D; Shinomiya, K | 1 |
Asai, S; Inagaki, N; Ito, T; Kato, H; Nagai, H; Tanaka, H; Yamashita, H | 1 |
Adham, M; Boillot, O; Dumortier, J; Guillaud, O; Pittau, G; Salandre, J; Scoazec, JY | 1 |
Alvarez-López, M; Casas Asuncion, E; Moreno, JC; Puya, R; Velez, A | 1 |
Avitan-Hersh, E; Bergman, R; Erisson, S; Solt, I | 1 |
Carlotti, DN; Fisch, RD; Fontaine, J; Guaguère, E; Olivry, T; Prélaud, P; Steffan, J | 1 |
Gordon, KB; McClure, SL; Valentine, J | 1 |
Anadolu, R; Calikoglu, E | 1 |
Bräuning, J; Heide, PE; Schlote, T; Tomida, I; Zierhut, M | 1 |
Harman, KE; Higgins, EM; Morris, SD | 1 |
Fusaro, M; Gallieni, M; Munaretto, G; Spinello, M | 1 |
Ferrer, L; Fondati, A; Gruet, P; Horn, J; Noli, C; Steffan, J; Strehlau, G | 1 |
Power, HT; Radowicz, SN | 1 |
Parks, C; Seewald, W; Steffan, J | 1 |
Aherne, CM; Baker, KP; Breathnach, RM; Jones, BR; McGeady, TA; Quinn, PJ | 1 |
Albani, J; Burdelski, M; Ganschow, R; Grabhorn, E; Richter, A | 1 |
Dissemond, J; Grabbe, S; Horsten, K | 1 |
Noli, C; Scarampella, F | 1 |
Wieczorek, D | 1 |
Cho, TH; Lee, MH | 1 |
Willemse, T; Wisselink, MA | 1 |
Ortiz de Frutos, FJ | 1 |
Benítez del Castillo, JM; del Aguila, C; Duran, S; García Sánchez, J; Hernandez, J | 1 |
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K | 1 |
Beljaards, RC; Bos, JD; De Rie, MA; Van Der Rhee, HJ; Wuite, J; Zeegelaar, J; Zonneveld, IM | 1 |
De Pita, O; Frezzolini, A; Lotti, T; Teofoli, P | 1 |
Bräutigam, M; Hultsch, T; Lotz, J; Schopf, RE | 1 |
Cachelin, AB; Kägi, MK; Wili, PB; Wüthrich, B; Zurbriggen, B | 1 |
Fontaine, J; Olivry, T | 1 |
Davidson, G; Jackson, HA; Murphy, KM; Olivry, T; Rivierre, C; Sousa, CA | 1 |
Wahlgren, CF | 1 |
12 review(s) available for cyclosporine and Pruritus
Article | Year |
---|---|
Pharmacological management of atopic dermatitis in the elderly.
Topics: Aged; Antibodies, Monoclonal, Humanized; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Pain; Pruritus; Treatment Outcome | 2020 |
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunologic Factors; Methotrexate; Network Meta-Analysis; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome | 2020 |
Adjunctive Management of Itch in Atopic Dermatitis.
Topics: Acupuncture Therapy; Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dietary Supplements; Emollients; Enzyme Inhibitors; Histamine Antagonists; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neurotransmitter Agents; Plant Oils; Pruritus; Ultraviolet Therapy | 2017 |
Chronic Urticaria: An Overview of Treatment and Recent Patents.
Topics: Adrenal Cortex Hormones; Angioedema; Animals; Blood Cell Count; Blood Sedimentation; C-Reactive Protein; Chronic Urticaria; Cyclosporine; Histamine H1 Antagonists, Non-Sedating; Humans; Immunologic Factors; Omalizumab; Pruritus; Quality of Life; Vasculitis | 2019 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
Update and insights into treatment options for chronic spontaneous urticaria.
Topics: Angioedema; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Drug Resistance; Histamine H1 Antagonists, Non-Sedating; Humans; Immunotherapy; Omalizumab; Pruritus; Skin; Urticaria | 2014 |
The maddening itch: an approach to chronic urticaria.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Omalizumab; Pruritus; Urticaria | 2014 |
Atopic itch in dogs: pharmacology and modeling.
Topics: Animals; Cyclosporine; Disease Models, Animal; Dog Diseases; Dogs; Glucocorticoids; Histamine Antagonists; Janus Kinase 1; Pruritus | 2015 |
Itch in Urticaria Management.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Omalizumab; Pruritus; Urticaria | 2016 |
Itch in Atopic Dermatitis Management.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aprepitant; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Emollients; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Phototherapy; Pruritus | 2016 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
[Atopic dermatitis and tacrolimus in adults].
Topics: Adrenal Cortex Hormones; Adult; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Middle Aged; Neoplasms; Pruritus; Retrospective Studies; Spain; Tacrolimus; Young Adult | 2008 |
15 trial(s) available for cyclosporine and Pruritus
Article | Year |
---|---|
Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Atopic; Female; Hypersensitivity; Male; Pilot Projects; Prospective Studies; Pruritus; Skin Diseases; Subcutaneous Absorption | 2018 |
Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Immunosuppressive Agents; Male; Prednisolone; Pruritus | 2013 |
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Male; Pruritus; Pyrimidines; Single-Blind Method; Sulfonamides; Treatment Outcome | 2015 |
The influence of non-specific anti-pruritus treatment with cyclosporine A on transepidermal water loss (TEWL) in natural atopic dermatitis in dogs.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Male; Pruritus; Water Loss, Insensible | 2015 |
Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis.
Topics: Animals; Canada; Cat Diseases; Cats; Cyclosporine; Dermatitis, Atopic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Immunosuppressive Agents; Male; Pruritus; Severity of Illness Index; Treatment Outcome; United States | 2016 |
Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Female; Male; Pruritus; Seasons; Severity of Illness Index; Treatment Outcome | 2002 |
Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Follow-Up Studies; Methylprednisolone; Pruritus; Recurrence; Risk Factors; Severity of Illness Index; Skin; Treatment Outcome | 2004 |
Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Pruritus; Safety; Treatment Outcome | 2005 |
The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
Topics: Animals; Blood Chemical Analysis; Cat Diseases; Cats; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Female; Hematologic Tests; Male; Prednisolone; Pruritus; Severity of Illness Index; Treatment Outcome | 2009 |
The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens.
Topics: Adolescent; Adult; Aged; Blood Pressure; Creatinine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pruritus; Sleep Wake Disorders; Treatment Outcome | 1996 |
Antipruritic effect of oral cyclosporin A in essential senile pruritus.
Topics: Administration, Oral; Aged; Antipruritics; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pruritus | 1998 |
Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
Topics: Blood Proteins; Cyclosporine; Dermatologic Agents; Eosinophil Granule Proteins; Eosinophils; Etretinate; Humans; Immunosuppressive Agents; Inflammation Mediators; Keratolytic Agents; Leukocyte Count; Pruritus; Psoriasis; Ribonucleases | 1998 |
Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
Topics: Adult; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Double-Blind Method; Emulsions; Female; Headache; Humans; Immunosuppressive Agents; Male; Middle Aged; Nausea; Pilot Projects; Pruritus; Severity of Illness Index; Sleep Wake Disorders; Time Factors; Treatment Outcome | 1999 |
Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Topics: Administration, Oral; Animals; California; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Female; Male; North Carolina; Prednisolone; Prospective Studies; Pruritus; Severity of Illness Index; Treatment Outcome; Virginia | 2002 |
Itch and atopic dermatitis: clinical and experimental studies.
Topics: Adolescent; Adult; Clemastine; Cyclosporine; Dermatitis, Atopic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Pruritus; Terfenadine | 1991 |
31 other study(ies) available for cyclosporine and Pruritus
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment.
Topics: Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Pruritus; Ultraviolet Therapy | 2020 |
Oral Alitretinoin for Patients with Refractory Prurigo.
Topics: Alitretinoin; Cyclosporine; Humans; Prurigo; Pruritus; Retrospective Studies | 2020 |
Combined Methotrexate and Alitretinoin for the treatment of difficult-to-treat generalized prurigo nodularis: a case series.
Topics: Alitretinoin; Cyclosporine; Humans; Methotrexate; Prurigo; Pruritus | 2021 |
Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Diagnosis, Differential; Hair Diseases; Hair Follicle; Humans; Immunologic Factors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver Transplantation; Male; Polyomavirus Infections; Pruritus | 2017 |
Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Cyclosporine; Dermatologic Agents; Eczema; Female; Humans; Keratoacanthoma; Keratolytic Agents; Keratosis, Actinic; Prurigo; Pruritus; Retrospective Studies | 2013 |
Feline non-flea induced hypersensitivity dermatitis: clinical features, diagnosis and treatment.
Topics: Alopecia; Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Erythema; Glucocorticoids; Histamine Antagonists; Pruritus | 2013 |
Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Female; Immunosuppressive Agents; Male; Pruritus; Skin | 2015 |
Inflammatory Disseminated Pruritic Porokeratosis With a Good Response to Ciclosporin.
Topics: Cyclosporine; Humans; Porokeratosis; Pruritus | 2016 |
Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
Topics: Administration, Topical; Animals; Antipruritics; Behavior, Animal; Cyclosporine; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Immunosuppressive Agents; Male; Mice; Mice, Inbred Strains; Pruritus; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Aspirin and loxoprofen relieve refractory pruritus in patients with prurigo nodularis.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Headache; Histamine Antagonists; Humans; Incidental Findings; Leg Injuries; Male; Middle Aged; Phenylpropionates; Prurigo; Pruritus; Roxithromycin; Treatment Failure; Visual Analog Scale | 2016 |
Lichen planopilaris and psoriasis.
Topics: Adult; Alopecia; Betamethasone; Cyclosporine; Drug Therapy, Combination; Epidermis; Female; Granulocytes; Humans; Lichen Planus; Lymphocytes; Plasma Cells; Pruritus; Psoriasis; Scalp Dermatoses | 2008 |
Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
Topics: Administration, Topical; Ambrosia; Animals; Anti-Allergic Agents; Betamethasone; Capillary Permeability; Cell Degranulation; Conjunctivitis, Allergic; Cromolyn Sodium; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Ketotifen; Male; Mast Cells; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Ovalbumin; Pruritus | 2009 |
Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
Topics: Animals; Antipruritics; Behavior, Animal; Calcineurin Inhibitors; Capillary Permeability; Cyclosporine; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Pruritus; Tacrolimus | 2010 |
Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.
Topics: Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Exanthema; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Pruritus; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
Treatment of severe refractory adult atopic dermatitis with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; Female; Humans; Immunosuppressive Agents; Prednisone; Pruritus; Severity of Illness Index; Ultraviolet Therapy; Ustekinumab; Young Adult | 2012 |
[Generalized pustular psoriasis of pregnancy].
Topics: Administration, Intravenous; Biopsy; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Female; Glucocorticoids; Humans; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third; Pruritus; Psoriasis; Skin; Treatment Outcome; Ultraviolet Therapy; Young Adult | 2012 |
Management of generalized pruritus in dominant dystrophic epidermolysis bullosa using low-dose oral cyclosporin.
Topics: Administration, Oral; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermolysis Bullosa Dystrophica; Female; Follow-Up Studies; Humans; Pruritus; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Topical cyclosporine A (2%) eyedrops in the therapy of atopic keratoconjunctivitis and keratoconjunctivitis vernalis.
Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Lacrimal Apparatus Diseases; Male; Ophthalmic Solutions; Palliative Care; Pruritus; Visual Acuity | 2002 |
Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin.
Topics: Adult; Anticonvulsants; Biopsy; Cyclosporine; Dermatologic Agents; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Interleukin-5; Lamotrigine; Phenytoin; Pruritus; Triazines | 2003 |
Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient.
Topics: Aged; Cyclosporine; Female; Humans; Pruritus; Renal Dialysis; Uremia | 2004 |
Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Administration Schedule; Female; Male; Pruritus; Retrospective Studies; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2005 |
Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis.
Topics: Animals; Anti-Inflammatory Agents; CD4-CD8 Ratio; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Foot Dermatoses; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Subsets; Male; Prednisolone; Pruritus; Treatment Outcome | 2005 |
Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
Topics: Adolescent; Child; Cholestasis; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Liver; Liver Transplantation; Postoperative Complications; Pruritus; Retrospective Studies; Tacrolimus | 2006 |
[Pruritus without skin findings].
Topics: Antidepressive Agents, Tricyclic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Pruritus; Psychotherapy; Time Factors | 2006 |
Prospective open pilot study on the use of ciclosporin for feline allergic skin disease.
Topics: Alopecia; Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Dose-Response Relationship, Drug; Erythema; Female; Male; Pilot Projects; Prospective Studies; Pruritus; Severity of Illness Index; Treatment Outcome | 2006 |
[Treating chronic urticaria].
Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosis, Differential; Histamine Antagonists; Humans; Pruritus; Urticaria | 2006 |
A case of lichen amyloidosus accompanied by vesicles and dyschromia.
Topics: Adult; Amyloidosis; Cyclosporine; Dermatitis, Photoallergic; Humans; Immunosuppressive Agents; Lichenoid Eruptions; Male; Pruritus; Skin Diseases, Vesiculobullous; Sunlight; Sunscreening Agents; Treatment Outcome | 2008 |
Influence of topically applied cyclosporine A in olive oil on corneal epithelium permeability.
Topics: Administration, Topical; Adult; Cell Membrane Permeability; Cornea; Corneal Diseases; Cyclosporine; Emulsions; Female; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Male; Olive Oil; Ophthalmic Solutions; Plant Oils; Pruritus | 1994 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous | 1996 |
Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.
Topics: Administration, Oral; Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Immunosuppressive Agents; Pilot Projects; Pruritus | 2001 |